prof. Valerie Fonteyne
- Work address
-
C. Heymanslaan 10, ingang 46 - verdieping 4
9000 Gent - vhfontey.Fonteyne@UGent.be
- ORCID iD
-
0000-0001-6724-1595
Show
Sort by
-
Physical activity and health-related quality of life from diagnosis to one year after radical cystectomy in patients with bladder cancer : a longitudinal cohort study
-
- Journal Article
- A1
- open access
Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
-
International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup
-
- Journal Article
- A1
- open access
Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial
-
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial
-
- Journal Article
- A1
- open access
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
-
- Journal Article
- A1
- open access
The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry
-
Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review
-
Supportive roles of the health care team throughout the illness trajectory of bladder cancer patients undergoing radical cystectomy : a qualitative study exploring the patients’ perspectives